Previous Next
In recent years, major advances have been made in the treatment of advanced hepatocellular carcinoma. However, a significant proportion of patients still show resistance to these treatments. Precision therapies are increasingly taking into account the unique molecular and cellular characteristics of each tumor to personalize treatment regimens. The aim is to improve anti-cancer efficacy while reducing the burden of side effects. To date, the use of precision therapy in hepatocellular carcinoma remains marginal. In this review, the authors present the latest data on therapeutic biomarkers, molecular classifications and the heterogeneity of the tumor microenvironment.

Source(s) :
Xupeng Yang et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024 Feb 12;42(2):180-197. ;

Last press reviews


COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths...

Resistance training and Multiple Sclerosis: a solution to improve function and quality of life?

Multiple sclerosis (MS) is a chronic autoimmune disease of the central ner...

Endometriosis: the Impact of hormones, sexual practice, and surgical treatments

Endometriosis is a chronic inflammatory disease modulated by estrogen leve...